0000875320-26-000136.txt : 20260306 0000875320-26-000136.hdr.sgml : 20260306 20260306160556 ACCESSION NUMBER: 0000875320-26-000136 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260304 FILED AS OF DATE: 20260306 DATE AS OF CHANGE: 20260306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McKechnie Duncan CENTRAL INDEX KEY: 0002062139 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 26730880 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 wk-form4_1772831152.xml FORM 4 X0508 4 2026-03-04 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0002062139 McKechnie Duncan C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Commercial Officer 1 Common Stock 2026-03-04 4 S 0 2437 475.30 D 15122 D Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. /s/ Christiana Stevenson, Attorney-in-Fact 2026-03-06